ArticleCancer immunology, immunotherapy : CII2022

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.

Bindu Varghese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.